Patents by Inventor Herbert Weich

Herbert Weich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITORS OF ALPHA-HEMOLYSIN OF STAPHYLOCOCCUS AUREUS
    Publication number: 20240376084
    Abstract: The present invention relates to novel inhibitors of ?-hemolysin of formula (I) and the use thereof for the prophylaxis and treatment of infections caused by Staphylococcus aureus; especially S. aureus lung infections.
    Type: Application
    Filed: July 7, 2022
    Publication date: November 14, 2024
    Inventors: Raffaella Dilucrezia, Mark Brönstrup, Ursula Bilitewski, Carsten Degenhart, Klaus Dinkel, Karoline Jerye, Eyad Kalawy Fansa, Vadim Korotkov, Eva Medina, Katharina Rox, Aditya Shekhar, Herbert Weich
  • PDGF-AB, preparation process and pharmaceuticals containing them
    Patent number: 5968778
    Abstract: The invention relates to a process for the preparation of PDGF-A and to biologically active PDGF-AA and PDGF-AB.
    Type: Grant
    Filed: February 24, 1997
    Date of Patent: October 19, 1999
    Assignee: Jurgen Hoppe
    Inventors: Jurgen Hoppe, Herbert Weich
  • PDGF-B fusion protein, vectors, and host cells for use in production thereof
    Patent number: 5334532
    Abstract: The present invention provides a method for production of recombinant PDGF-B in prokaryotic cells. Also provided are DNA constructs for fusion protein useful in the production of the biologically active product.
    Type: Grant
    Filed: June 4, 1991
    Date of Patent: August 2, 1994
    Assignee: ImClone Systems Incorporated
    Inventors: Charles Tackney, Jurgen Hoppe, Wolfram Eichner, Herbert Weich